What is it about?
Nanoparticles are increasingly used to deliver drugs directly to specific parts of the body, helping treatments become more effective while reducing side effects. However, once inside the body, nanoparticles face many biological barriers, and only a small fraction actually reaches the target cells. In this study, we developed a computational model to better understand and optimize how nanoparticles move through the body. The model divides the body into five key “compartments” (such as the bloodstream, target tissue, and excretion pathways) and simulates how nanoparticles travel between them.  Using this approach, we can estimate how efficiently nanoparticles deliver drugs and identify the most important factors that influence their performance. A case study with PEG-coated gold nanoparticles targeting the lungs showed that the model can accurately reproduce real biological behavior and highlight which parameters matter most.  The model is available as an easy-to-use web application through the CompSafeNano Cloud Platform, allowing researchers to run virtual experiments and optimize nanoparticle designs without the need for laboratory testing.
Featured Image
Photo by Shubham Dhage on Unsplash
Why is it important?
One of the biggest challenges in nanomedicine is that most nanoparticles do not reach their intended target, reducing treatment effectiveness and potentially causing unwanted side effects. This work is important because it provides a simple but powerful tool to simulate and optimize nanoparticle drug delivery before experiments are performed. By identifying the key factors that control nanoparticle distribution, researchers can design more efficient and targeted therapies. The approach also reduces reliance on animal testing and costly experimental studies, supporting more ethical and sustainable research practices.  Additionally, the ability to run in silico experiments enables faster development of precision medicine strategies, where treatments can be tailored for specific diseases or patient conditions.
Perspectives
This work highlights the value of combining mathematical modeling with cloud-based tools to make complex biological simulations accessible to a wider research community. From a personal perspective, one of the key strengths is the balance between simplicity and usefulness. While the model is relatively simple compared to full biological systems, it captures the essential processes that determine nanoparticle behavior and provides actionable insights for optimization. Looking ahead, integrating this type of modeling with experimental data and machine learning could further improve predictive accuracy and expand its applications to more complex biological systems and different types of nanoparticles. Such approaches will play an important role in advancing nanomedicine, enabling smarter design of drug delivery systems and accelerating the development of safer and more effective therapies.
Dr Antreas Afantitis
NovaMechanics Ltd
Read the Original
This page is a summary of: Optimizing nanoparticle-mediated drug delivery: insights from compartmental modeling via the CompSafeNano cloud platform, RSC Sustainability, January 2025, Royal Society of Chemistry,
DOI: 10.1039/d4su00686k.
You can read the full text:
Contributors
The following have contributed to this page
